Overview

A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease

Status:
Completed

Trial end date:
2008-07-01

Target enrollment:

Participant gender:

Summary

To assess safety and tolerability of ALV003 in healthy volunteers and patients with Celiac Disease

Phase:

Phase 1

Details

Lead Sponsor:

Alvine Pharmaceuticals Inc.